Personalized Prone Immobilization for Accelerated Partial Breast Radiotherapy

The goal of this clinical trial is to find out whether using a personalized breast holder (called VENUS SHELL™) can improve positioning and patient comfort during prone radiotherapy (radiotherapy given while the patient lies on her stomach). The main goals of the study are: * To confirm that using the VENUS SHELL™ is safe and effective * To assess whether the VENUS SHELL™ helps deliver accurate radiation treatment in a faster and more comfortable way Participants will: * Attend a study visit before radiotherapy to have a breast surface scan (no radiation) and enable the production of their

Trial Details

NCT ID
NCT07711847
Phase
NA
Sponsor
HeroSupport SA
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • VENUS SHELL™ immobilization device
Locations (sample)
  • New York, New York, United States|40.71427,-74.00597

Key Eligibility Criteria

  • Written informed consent according to ICH/GCP regulations before registration and prior to any study-specific procedures
  • Upfront breast conservative surgery
  • Radiotherapy planned within 12 weeks after surgery
  • ECOG/WHO performance status ≤2

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →